Macmillan Warns Cancer Patients on Weight-Loss Jabs

Macmillan Cancer Support has warned cancer patients about using popular weight-loss injections, specifically GLP-1 receptor agonists such as Wegovy and Mounjaro, and emphasized the need for medical consultation before use. The charity has seen a surge in patient questions regarding the safety, effectiveness, and potential drug interactions of these medications during cancer treatment. Evidence is currently insufficient to recommend these drugs for cancer patients outside of specialist care, and there are concerns over possible links to thyroid cancer. The medications may also interfere with the absorption of other drugs, including crucial anti-cancer treatments. Macmillan encourages patients to seek individualized medical guidance instead of relying on 'quick fix' solutions, and highlights the continued importance of healthy eating and physical activity. The organization calls for further research to better understand the risks and benefits of these drugs for cancer patients.